{"id":"https://openalex.org/W96315799","doi":null,"title":"Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.","display_name":"Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W96315799","mag":"96315799","pmid":"https://pubmed.ncbi.nlm.nih.gov/18197742"},"language":"en","primary_location":{"id":"pmid:18197742","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18197742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W96315799"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087059050","display_name":"GEORGE E. DAILEY","orcid":"https://orcid.org/0000-0002-2906-445X","observed_orcids":["https://orcid.org/0000-0002-2906-445X"]},"institutions":[{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Dailey","raw_affiliation_strings":["Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA 92037, USA. gdailey@scrippsclinic.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA 92037, USA. gdailey@scrippsclinic.com","institution_ids":["https://openalex.org/I4210146328"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052946442","display_name":"Poul Strange","orcid":"https://orcid.org/0000-0001-5330-0769","observed_orcids":["https://orcid.org/0000-0001-5330-0769"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Poul Strange","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7135,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.72953498,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"14","issue":"1","first_page":"25","last_page":"30"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.14869999885559082,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/nph-insulin","display_name":"NPH insulin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/severe-hypoglycemia","display_name":"severe hypoglycemia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9210000038146973},{"id":"https://openalex.org/keywords/basal-insulin-analogues","display_name":"basal insulin analogues","score":0.925000011920929},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.7120000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9457086324691772},{"id":"https://openalex.org/C2778804033","wikidata":"https://www.wikidata.org/wiki/Q1929845","display_name":"NPH insulin","level":5,"score":0.8673911094665527},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.8556995391845703},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.8533511757850647},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.7160768508911133},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6174421310424805},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6000494360923767},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5719160437583923},{"id":"https://openalex.org/C2776664568","wikidata":"https://www.wikidata.org/wiki/Q742283","display_name":"Insulin analog","level":4,"score":0.5564092397689819},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5359628200531006},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.5054261684417725},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4573606252670288},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38710281252861023},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.37048184871673584},{"id":"https://openalex.org/C3019948211","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Human insulin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007345","descriptor_name":"Insurance Claim Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015201","descriptor_name":"Meta-Analysis as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016347","descriptor_name":"Medical Records Systems, Computerized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18197742","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18197742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},{"id":"mag:96315799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18197742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W594361696","https://openalex.org/W1975019670","https://openalex.org/W1975588287","https://openalex.org/W1996441843","https://openalex.org/W1997373335","https://openalex.org/W2007262124","https://openalex.org/W2019905477","https://openalex.org/W2035042051","https://openalex.org/W2059025673","https://openalex.org/W2059158127","https://openalex.org/W2063423309","https://openalex.org/W2078089300","https://openalex.org/W2079889285","https://openalex.org/W2085381118","https://openalex.org/W2086666326","https://openalex.org/W2102561025","https://openalex.org/W2123946565","https://openalex.org/W2126781806","https://openalex.org/W2132861529","https://openalex.org/W2136498440","https://openalex.org/W2139634859","https://openalex.org/W2149194615","https://openalex.org/W2158573360","https://openalex.org/W2160379357","https://openalex.org/W2168959099","https://openalex.org/W2337454357","https://openalex.org/W2993807072","https://openalex.org/W4254695749"],"related_works":["https://openalex.org/W2168959099","https://openalex.org/W2809290132","https://openalex.org/W1978822680","https://openalex.org/W2113205190","https://openalex.org/W2108801532","https://openalex.org/W2027781446","https://openalex.org/W2027930937","https://openalex.org/W2032739316","https://openalex.org/W2042050025","https://openalex.org/W2586985323"],"abstract_inverted_index":{"Hypoglycemia":[0],"is":[1,56],"a":[2,68,95],"common":[3],"consequence":[4],"of":[5,61,98,116,128,144,155],"achieving":[6],"tight":[7],"glycemic":[8,72],"control":[9,73],"for":[10,48,58],"patients":[11,49],"with":[12,16,103,120,164,168],"type":[13,75],"2":[14,76],"diabetes,":[15],"clinical":[17,80,149,172],"effects":[18],"ranging":[19],"from":[20,79,147,171],"occasional":[21],"mild":[22],"discomfort":[23],"to":[24,70,124,135],"incapacitation,":[25],"coma,":[26],"or":[27,42],"in":[28,38,74,94,140],"rare":[29],"cases,":[30],"death.":[31],"Severe":[32],"hypoglycemic":[33,100],"events,":[34,63],"particularly":[35],"those":[36],"resulting":[37],"emergency":[39],"medical":[40,46,156],"intervention":[41],"hospitalization,":[43],"incur":[44],"substantial":[45],"costs":[47],"and":[50,82,130,137,152],"the":[51,59,87,126,169],"healthcare":[52],"system.":[53],"Although":[54],"vigilance":[55],"needed":[57],"possibility":[60],"severe":[62,99,131],"hypoglycemia":[64,132,145],"need":[65],"not":[66],"be":[67],"barrier":[69],"effective":[71],"diabetes.":[77],"Data":[78],"trials":[81],"meta-analyses":[83],"have":[84,160],"demonstrated":[85],"that":[86],"basal":[88],"insulin":[89,91,105,117,122,165],"analog":[90],"glargine":[92,118],"results":[93],"reduced":[96,162],"rate":[97],"events":[101],"compared":[102,119],"conventional":[104],"therapy":[106],"such":[107],"as":[108],"neutral":[109],"protamine":[110],"Hagedorn":[111],"(NPH)":[112],"insulin.":[113],"Overall,":[114],"use":[115],"NPH":[121],"appears":[123],"reduce":[125],"risk":[127],"nocturnal":[129],"by":[133],"40%":[134],"60%":[136],"may":[138],"result":[139],"cost":[141],"savings.":[142],"Analyses":[143],"rates":[146,163],"\"real-world\"":[148],"practice":[150],"databases":[151],"retrospective":[153],"analyses":[154],"claims":[157],"data":[158],"also":[159],"revealed":[161],"glargine,":[166],"consistent":[167],"findings":[170],"trials.":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W96315799","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
